Диссертация (1139884), страница 18
Текст из файла (страница 18)
Circ Heart Fail. 2012 May 1;5(3):322-30. Epub 2012Mar 22.48.Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotionson prognosis following myocardial infarction: is it more than depression?Health Psychol 1995; 14:388–398.49.Fuster V, Ryde´n LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for theManagementofPatientsWithAtrialFibrillation:Circulation2001;104(17):2118-50.50.Gage BF, Cardinalli AB, Owens DK. The effect of stroke and strokeprophylaxis with aspirin or warfarin on quality of life.
Arch Intern Med.1996;156(16):1829–1836.51.Garcia-Cebrian A, Bauer M, Montejo AL, Dantchev N, Demyttenaere K,Gandhi P, Grassi L, Monz BU, Perahia DG, Quail D, Tylee A. Factors113influencing depression endpoints research (FINDER): study design andpopulation characteristics. Eur Psychiatry. 2008 Jan;23(1):57-65.52.Gehi AK, Sears S, Goli N, Walker TJ, Chung E, Schwartz J, WoodKA, Guise K, Mounsey JP. Psychopathology and Symptoms of AtrialFibrillation: Implications for Therapy.
J Cardiovasc Electrophysiol. 2012Mar 19. [Epub ahead of print].53.Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrialfibrillation in adults: national implications for rhythm management andstroke prevention: the AnTicoagulation and Risk Factors in AtrialFibrillation (ATRIA) Study. JAMA 2001;285:2370–5.54.Goldberg A, Menen M, Mickelsen S, MacIndoe C, Binder M, Nawman R,West G, Kusumoto FM.
Atrial fibrillation ablation leads to long-termimprovement of quality of life and reduced utilization of healthcareresources. J Interv Card Electrophysiol 2003;8:59–64.55.Groenveld HF, Crijns HJ, Van den Berg MP, Van Sonderen E et al; RACEII Investigators. The effect of rate control on quality of life in patients withpermanent atrial fibrillation: data from the RACE II (Rate Control Efficacyin Permanent Atrial Fibrillation II) study.
J Am Coll Cardiol. 2011 Oct18;58(17):1795-803.56.Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH. Impact of rate versusrhythm control on quality of life in patients with persistent atrial fibrillation.Results from a prospective randomized study. Eur Heart J 2003;24:1430–143657.Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, TijssenJG, Kingma JH, Crijns HJ, van Gelder IC. RACE Study Group. Effect ofrate or rhythm control on quality of life in persistent atrial fibrillation.Results from the Rate Control versus Electrical Cardioversion (RACE)Study. J Am Coll Cardiol 2004;43:241–247.11458.Hayman KJ, Kerse NM, La Grow SJ, Wouldes T, Robertson MC, CampbellAJ. Depression in older people: visual impairment and subjective ratings ofhealth.
Optom Vis Sci. 2007 Nov;84(11):1024-30.59.Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, CarbucicchioC, Kottkamp H. Perception of atrial fibrillation before and afterradiofrequency catheter ablation: Relevance of asymptomatic arrhythmiarecurrence. Circulation 2005;112:307–313.60.Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrialfibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): Arandomised trial.
Lancet 2000;356:1789–1794.61.Howes CJ, Reid MC, Brandt C, Ruo B, Yerkey MW, Prasad B, Lin C,Peduzzi P, Ezekowitz MD. Exercise tolerance and quality of life in elderlypatients with chronic atrial fibrillation. J Cardiovasc Pharmacol Ther2001;6:23–29.62.Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y,Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M.Catheter ablation for atrial fibrillation in congestive heart failure. N Engl JMed 2004;351:2373–2383.63.IwasakiYK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology:implications for management. Circulation. 2011 Nov 15;124(20):2264-74.64.Jenkins LS, Brodsky M, Schron E et al. Quality of life in atrial fibrillation:the Atrial Fibrillation: the Follow-up Investigation of Rhythm Management(AFFIRM) study.
Am Heart J., 2005; 149(1):112-20.65.Jessurun ER, van Hemel NM, Defauw JAMT et al. Results of Maze surgeryfor lone paroxysmal atrial fibrillation. Circulation 2000; 101:1559–67.66.Joffe H, Chang Y, Dhaliwal S, Hess R, Thurston R, Gold E, Matthews KA,Bromberger JT. Lifetime history of depression and anxiety disorders as apredictor of quality of life in midlife women in the absence of current illnessepisodes.
Arch Gen Psychiatry. 2012 May;69(5):484-92.11567.Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, MianulliM, Wilkoff B. The Ablate and Pace Trial: A prospective study of catheterablation of the AV conduction system and permanent pacemakerimplantation for treatment of atrial fibrillation.
J Interv Card Electrophysiol1998;2:121–135.68.Kerr CR, Boone J, Connolly SJ, Dorian P, Green M, Klein G, Newman D,Sheldon R, Talajic M. The Canadian Registry of Atrial Fibrillation: Anoninterventional follow-up of patients after the first diagnosis of atrialfibrillation. Am J Cardiol 1998;82(7 suppl 1):82N–85N.69.Khairy P, Nattel S. New insights into the mechanisms and management ofatrial fibrillation.
CMAJ 2002; 167: 1012–20.70.Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrialfibrillation: executive summary. Recommendations from a consensusconference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). EurHeart J 2007;28:2803–17.71.Kneeland PP, Fang MC. Current issues in patient adherence and persistence:focusonanticoagulantsforthetreatmentandpreventionofthromboembolism.
Patient Prefer Adherence. 2010 Mar 24;4:51-60.72.Kovacs KA. Long-term management of atrial fibrillation: rhythm or ratecontrol? CMAJ 2003; 168: 591–2.73.Kumana CR, Cheung BMY, Cheung GTY, Ovedal T, Pederson B, LauderIJ. Rhythm vs. rate control of atrial fibrillation meta-analysed by numberneeded to treat. Br J Clin Pharmacol 2005; 60 (4): 347–354.74.Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-termwarfarin therapy on quality of life.
Evidence from a randomized trial.Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. ArchIntern Med. 1991;151(10):1944–1949.11675.Lane D, Carroll D, Ring C, et al. Effects of depression and anxiety onmortality and quality-of-life 4 months after myocardial infarction. JPsychosom Res 2000; 49:229–238.76.Lane D, Carroll D, Ring C, et al. In-hospital symptoms of depression do notpredict mortality 3 years after myocardial infarction. Int J Epidemiol 2002;31:1179–1182.77.Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 monthsafter myocardial infarction: effects of depression and anxiety.
PsychosomMed 2001; 63:221–230.78.Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high riskfor stroke despite anticoagulation: a comparison of contemporary stroke riskstratification schemes in an anticoagulated atrial fibrillation cohort. Stroke.2010 Dec;41(12):2731-8.79.Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development ofatrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042–6.80.Locadia M, Sprangers MA, de Haes HC, Buller HR, Prins MH. Quality oflife and the duration of treatment with vitamin K antagonists in patients withdeep venous thrombosis. Thromb Haemost. 2003;90(1):101–107.81.Lonnerholm S, Blomstrom P, Nilsson L, Oxelbark S, Jideus L, BlomstromLundqvist C.
Effects of the maze operation on health-related quality of lifein patients with atrial fibrillation. Circulation 2000;101:2607–2611.82.Luderitz В, Jung W. Quality of Life in Patients With Atrial Fibrillation.Arch Intern Med. 2000;160:1749-1757.83.MagnaniJW, RienstraM, LinH, SinnerMF, LubitzSA, McManusDD, Dupuis J, Ellinor PT, Benjamin EJ.
Atrial fibrillation: currentknowledge and future directions in epidemiology and genomics.Circulation. 2011;124(18):1982-93.11784.Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanicalfunction after cardioversion: relation to the duration of atrial fibrillation. JAm Coll Cardiol. 1994;23:1535-40.85.Marining R, Lip GY, Lane DA, Stroke prevention in atrial fibrillationpatients.
Expert Opin Pharmacother. 2010;11(14):2331-50.86.McCabe PJ, Schumacher K, Barnason SA. Living with atrial fibrillation: aqualitative study. J Cardiovasc Nurs. 2011 Jul-Aug;26(4):336-44.87.McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-item short-formhealth survey (SF-36), II: psychometric and clinical tests validity inmeasuring physical and mental health const ructs.
Med. Care., 1993;31:24763.88.Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR,Abhayaratna WP,Seward JB, Tsang TS. Secular trends inincidence of atrial fibrillation inOlmsted County, Minnesota,1980 to 2000, and implications on theprojections for futureprevalence. Circulation 2006;114:119–25.89.Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence ofatrial fibrillation and flutter in the United States. Am J Cardiol2009;104:1534–9.90.Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, Bates ER,Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V,Morady F.
Circumferential pulmonary-vein ablation for chronic atrialfibrillation. N Engl J Med 2006;354:934–941.91.Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, WilkinsonWE, Pritchett EL. Asymptomatic or “silent” atrial fibrillation: Frequency inuntreatedpatientsandpatientsreceivingazimilide.Circulation2003;107:1141–1145.92.Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P,Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S,Zangrillo A, Crescenzi G, Benussi S, Alfieri O. Mortality, morbidity, andquality of life after circumferential pulmonary vein ablation for atrial118fibrillation: Outcomes from a controlled nonrandomized long-term study.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
